Immunogenicity of inactivated quadrivalent influenza vaccine in pregnant women, including the level of postvaccination antibodies in umbilical cord blood
It is necessary to increase knowledge about the safety and effectiveness of influenza vaccination during pregnancy to improve awareness among patients and healthcare professionals and increase to increase vaccination coverage.
Comparative effectiveness of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in children over multiple influenza seasons (2019–2023)
Annual vaccination with LAIV4 or IIV4 remains the best way to protect children against influenza infection.
European Vaccine Hub to enhance health preparedness across EU
The initiative consist of key actions, that will amongst others, speed-up vaccine development to less than four months from identifying a pathogen's genomic sequence.
News
Policy & Recommendations
Promoting vaccination amongst the elderly with VITAL’s new tools
The VITAL project published an educational platform as well as a toolbox to boost vaccination uptake amongst older people.
mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine in healthy adults: a phase 1/2 trial
A multicomponent vaccine targeting several seasonal respiratory pathogens may provide simultaneous protection in a single-injection regimen.
Next-generation seasonal influenza virus vaccines need a neuraminidase component
This commentary highlights the potential need to incorporate neuraminidase components into future influenza vaccines
Interim data on flu vaccines estimate overall moderate protection in Europe and China
Estimates of current mid-season flu vaccine effectiveness (VE) in Europe and China range from 32% to 58% overall, with greater protection against influenza B than A, according to three studies published in Eurosurveillance.
